Auto-generated event page

Cogent Biosciences Highlights Additional Data with Six Bezuclastinib Posters from SUMMIT Trial at 2026 AAAAI Annual Meeting

WALTHAM, Mass. and BOULDER, Colo., Feb. 28, 2026 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies f...

Score 41 low confidence 1 source posts Updated Feb 28, 2026, 3:00 PM UTC

Track This Event Open Event in App More Signal Pages

Cluster sources

Newest source rows first.

Cogent Biosciences Highlights Additional Data with Six Bezuclastinib Posters from SUMMIT Trial at 2026 AAAAI Annual Meeting

GlobeNewswire Public Companies • Feb 28, 2026, 2:45 PM UTC

Entity focus

Direct link to post

https://pushme.site/signals/161361-cogent-biosciences-highlights-additional-data-with-six-bezuclastinib-pos?utm_source=signal-161361&utm_medium=social&utm_campaign=signal-pages&utm_content=hero

Quick distribution loop

Step 1

Post this live link in threads where users ask how to monitor this event.

Step 2

Point readers to "Track This Event" for immediate conversion into an alert.

Step 3

Reuse entity keywords from this page for targeted follow-up replies.

Back to signal pages Open query hub